Table 1. Summary of clinico-pathologic characteristics (N = 613).
| Parameter | Number (%) |
|---|---|
| Age (Median, range; years) | 66 (44–89) |
| Initial PSA level (Median, range; ng/dL) | 8.0 (1–79) |
| Gleason score ≤6 | 342 (55.8) |
| 3+4 | 128 (20.9) |
| 4+3 | 74 (12.1) |
| ≥8 | 79 (12.9) |
| Tumor multiplicity single | 192 (31.3) |
| multiple | 421 (68.7) |
| Extra-prostatic capsule extension | 205 (33.4) |
| Positive surgical margin | 154 (25.1) |
| Positive lymphovascular invasion | 50 (8.2) |
| Positive perineural invasion | 340 (55.5) |
| Seminal vesicle invasion | 75 (12.2) |
| High grade PIN | 352 (57.4) |
| pTstage by AJCC 7th. Edition* | |
| pT2 | 405 (65.0) |
| pT3 | 177 (34.5) |
| pT4 | 1 (0.5) |
| pN+ | 28 (5.8) |
| Biochemical recurrence | 132 (21.5) |
| Median follow-up duration (months) | 44.0 (12–154) |
*, Edge SB, Byrd DR, Compton CC, et al, eds. AJCC Cancer Staging Manual. 7th ed. American Joint Committee on Cancer. Chicago: Springer-Verlag; 2010.